Rasmussen's encephalitis (RE) is a rare and devastating unilateral inflammatory brain disease that causes severe and intractable partial epilepsy. It has been shown that epilepsy and subsequent inflammation have deleterious influence on hippocampal cell survival and neurogenesis, but this still has not been systematically explored in human tissue. In this study, we investigated the correlation between inflammation and epilepsy as well as the rates of hippocampal gliogenesis and neurogenesis in a pediatric group of six patients with RE and six control cases. The dentate gyrus (DG) samples were obtained from patients who underwent surgery for intractable RE. Sections were processed for immunohistochemistry using antibodies against sex determining region Y-box 2 (Sox2), nestin, human protein encoded by MKI67 gen (Ki67), and brain-derived neurotrophic factor (BDNF). There was an increase in the number of Ki67-positive granule cells in the DG of patients with RE in comparison with the autopsy control group, but no statistical difference for Sox2-positive cells was observed between these groups. Nestin immunolabeling was less intense in the RE group while BDNF expression was increased. Neurons that were BDNF-positive were found in DG from patients with RE but not in the control group. In patients with RE, few nestin-positive cells in DG were also positive for BDNF, unlike in controls which showed no colocalization for these two markers. These results suggest a proliferation activity in the DG subfield of patients with RE, and also future studies are necessary to address the role of new cells in the hippocampus of patients with RE.
Introduction
Rasmussen's encephalitis (RE) is an inflammatory disease frequently observed in children aged 3 to 11 years old. Its main symptom is the frequent occurrence of seizures refractory to most known anticonvulsant drugs, and its most significant underlying substrate is the presence of a severe inflammatory process limited to one cerebral hemisphere that may progressively culminate in hemiparesis or contralateral hemiplegia to the affected hemisphere. The strong inflammatory component involves microglia activation, numerous microglial nodules, astrocytosis, and cytotoxic T-cell recruitment culminating in neuronal loss [1] .
The etiology of RE is not fully established, but it has been long believed that viral infection in early childhood plays a role on the pathophysiology of the disease [2] . Nevertheless, a final demonstration of a viral agent for RE has not been accomplished yet [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
Neurogenesis is a persistent brain ability to generate new neurons from neural stem/progenitor cells (NSCs), as demonstrated by the remarkable work by Joseph Altman and Gopal Das in the 1960s, which first suggested that the adult brain has the ability to generate these new brain cells [13] . Similar suggestions were made by Michael Kaplan in the 1970s [14] for mammalian brains and by Fernando Nottebohm in the 1980s for avian brains [15] ; however, adult neurogenesis was accepted by the scientific community only in the early 1990s [16] [17] [18] .
Currently, it is well-established that there are two main neurogenic niches in the adult brain: the subventricular zone (SVZ) [19] on the wall of the lateral ventricles and subgranular zone (SGZ) on the hippocampal dentate gyrus (DG). In rodents, B cells (an astrocyte-like cell) generate neuroblasts that migrate to the olfactory bulb in which they are integrated in functional adult circuits [20] . In the hippocampus, progenitor cells generate neuroblasts, which migrate to the granular cell layer, then becoming new granular cells [21] . The meaning of adult neurogenesis is yet to be known, but it has been suggested that the new cells are important to the maintenance and repair of interneurons in the OB, modulation and refinement of adult circuits in the hippocampus, as well as to some specific kind of hippocampaldependent memory [22] .
Different factors such as an enriched environment [21] , learning [23] , stress [24, 25] , physical exercise [26] [27] [28] , seizures [29] , and inflammation [30, 31] influence adult neurogenesis. Also, seizures may play a controversial time-dependent role on increasing adult neurogenesis [32, 33] or diminishing it after long-term seizure episodes [34] .
Although further understanding on increased neurogenesis after seizures is needed, it may be some sort of effort made by the injured brain to replace cells lost after seizure activity. Nevertheless, it has been shown that the newly born cells do not survive for a long time after a neurological insult, which jeopardizes integration into adult circuits [30] . Moreover, these newly born cells probably form anomalous circuits, which can increase the occurrence of seizures instead of improving the patient's overall clinical condition [35] . On the other hand, the inflammation effects on the developing brain and neurogenesis rates are extensively researched, and the inflammatory process is accepted as essential for tissue maintenance and repair; however, exacerbated and long sustained inflammation is extremely harmful not only for normal brain maintenance but also for rates of physiological neurogenesis [36] . Together with the growing interest in neurogenesis, the factors that influence this phenomenon also instigate intense curiosity. Brainderived neurotrophic factor (BDNF) is a neurotrophin that has been associated with the occurrence of neurogenesis, but many authors associate this expression with an increase of brain injury in epilepsy [37] . Rasmussen's encephalitis is a good candidate to understand this correlation because this disease presents both of these processes together. Furthermore, there is no well-established information about such correlation between RE and neurogenesis, neither in humans nor in an animal model of epilepsy. Therefore, the present study aimed at evaluating neuronal cell loss, astrocytosis, neurogenesis rates, and neurotrophin BDNF pattern in hippocampal tissue from patients with RE in comparison with human autopsy control cases.
Material and methods

Human hippocampal tissue
Hippocampal specimens were obtained from 6 patients who underwent epilepsy surgery at the Erlangen Epilepsy Centre or São Paulo Hospital, Federal University of São Paulo, in which drug-resistant RE was diagnosed by preoperative evaluation. Presurgical epilepsy monitoring included interictal and ictal video-electroencephalography (video-EEG) monitoring, using 32-to 64-channel EEG, as well as magnetic resonance imaging (MRI) (1.5 Tesla Sonata Siemens, Munich, Germany) and neuropsychological evaluation. Intracarotid amobarbital procedure (WADA test), positron emission tomography (PET), magnetic encephalography, and intraoperative electrocorticography were applied when necessary to characterize the epileptogenic zone [38] . Mean duration of epilepsy was 2.8 years, ranging from 1 to 9 years. The average age at the surgery was 7.6 years, ranging from 3 to 15 years old (see Table 1 ). Informed and written consent was given by all patients included in our study for additional scientific investigations approved by the local ethics committee of the University of Erlangen. All procedures were conducted in accordance with the Declaration of Helsinki (1964) .
The control group consisted of autopsy cases (age range from 5 to 27 years old) from the University Hospital Erlangen, of which the cause of death was not related to the nervous system.
Histopathological examination
Each surgical hippocampus specimen was dissected into 5-mm thick slices along the anterior-posterior axis. Tissue from the mid-hippocampal body was fixed overnight in 10% formalin and routinely processed into liquid paraffin. All specimens were cut at 4 μm on a rotation microtome (Microm, Germany) and stained with hematoxylin and eosin. Hippocampal pyramidal neurons and granule cells of the DG were detected using immunohistochemistry for neuronal nuclei protein (NeuN) (Millipore, 1:1000) in an automated staining apparatus (Ventana, Strasbourg, France). Microwave pretreatment was applied for paraffinembedded tissue labeling.
Immunohistochemistry and immunofluorescence
The following antibodies were used: NeuN, anti-glial fibrillary acid protein (GFAP), nestin, BDNF, sex determining region Y-box 2 (Sox2), human protein encoded by MKI67 gen (Ki67), and β-III tubulin. Immunocytochemistry of fixed human hippocampus tissue and quantitative microscopic evaluation were performed as described earlier [39] . Primary antibodies were used at the following dilutions: mouse antiNeuN (1:100, Chemicon-Millipore®), goat anti-GFAP (1:100, DAKO®), Table 1 Patients' clinical history. Hippocampus subfield availability was the factor used to include the subjects. RE = patients with Rasmussen's encephalitis; F = female; M = male; NA = datum not available.
Patients
Clinical history Gender Age at epilepsy onset
Duration of epilepsy
Age at surgery RE1  F  2  1  3  Left  RE2  M  6  2  8  Left  RE3  F  6  9  15  Left  RE4  F  NA  NA  NA  NA  RE5  F  2  1  3  NA  RE6  F  8 mouse and goat anti-nestin (1:100, Millipore®), mouse anti-vimentin (1:100, Millipore®), mouse-anti-Ki67 (1:100, Chemicon®), goat antiSox2 (1: 100, Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-class III β tubulin (β-III tubulin, 1:100, Abcam®), and rabbit anti-BDNF (1:100, Chemicon-Millipore®). Secondary antibodies were obtained from Invitrogen and used in appropriate dilutions. Cellular nuclei were counterstained with DAPI (Sigma-Aldrich).
Side of resection
Semiquantitative analysis of pyramidal and granule-cell densities, astrocytes, Ki67 and Sox2 immunoreactive cells
Semiquantitative measurements of cell density were obtained from all patients using 4-μm thin paraffin sections and NeuN immunohistochemistry [39] . Hippocampal sectors CA1, CA2, CA3, and CA4 and the DG were examined at 40× objective microscope magnification. Ten randomly placed microscopic fields were examined for each anatomical subregion [39] . Measurements were performed with a microcomputer imaging system (ColorView II CCD camera, Soft Imaging System (SIS), Stuttgart, Germany) attached to a BX51 microscope (Olympus). Immunohistochemically stained neuronal cell bodies were tagged on the computer screen, counted within the region of interest, and expressed as the mean number of neurons/mm 2 using AnalySIS imaging software (SIS) and Excel software (Microsoft, Redmond, Washington, USA). The same methodology was applied for assessing the proliferation activity using Ki67 immunoreactivity. The subgranular and granule cell layers were analyzed in 6 patients from which sufficient material was available for preparing 10 serial 5-μm sections. Vimentin and Sox2+ cells were semiquantitatively estimated by the same method using fluorescence labeling. Four adjacent microscopic fields were placed into the DG granule cell layer at 40× objective magnification, and immunoreactive cell bodies were identified using appropriate filter combinations.
Statistical analysis
Statistic GraphPad package (Prism® 5.0) was used for statistical evaluation. The threshold for significance was set to 0.05. One-way analysis of variance (ANOVA) with Dunnett's multiple comparison posttest was used to compare individual cell measurement. Unpaired t-test with Bonferroni test was used to compare groups of subjects.
Results
Comparison of neuronal cell counting in the hippocampus of patients
Neuronal cell numbers and densities were quantitatively determined in all hippocampal subfields, including the pyramidal cell layer and granular cell layer of the DG. For an overview between the groups, we calculated cell density using an excel platform established in the Neuropathology Institute, University Hospital Erlangen, Germany that can estimate the hippocampal neuronal density from a known area count [40] . This same platform was used for astrocytes and newborn Ki-67 + cell counting in the hippocampus. Regarding the cell counting in both hippocampal pyramidal cell sector and granule cells of the DG, no statistical difference between patients with RE and control autopsy cases was found (p N 0.05, t-test), as seen in Fig. 1 .
Astrocyte cell measurement in the hippocampus of patients with RE
Astrocytes were accessed in the hippocampus of patients with RE and autopsy controls by using the GFAP immunomarker, a highly expressed cytoskeletal protein of astrocytes and, also, a commonly used marker for tissue gliosis analysis in both animal and human studies. Fig. 2 shows the comparison of astrocyte proliferation between the control group and the patients with RE. Astrocyte cell counting was performed in all hippocampal layers as well as in the DG, as done for neuronal cell counting. Fig. 2 displays the comparison between controls and patients with RE in which a decrease in the number of astrocytes, both in the CA4 hippocampal sector and in the DG, can be observed.
3.3. Proliferative activity analysis in patients with RE showed increase of Ki67 + cells in the DG hippocampal subfield but not in Sox2
In order to determine the proliferative activity in the hippocampal subfields in patients with RE and control cases from autopsy samples, we performed immunohistochemistry for Ki67, a nuclear protein associated with proliferative activity and ribosomal ribonucleic acid (RNA) transcription [41] . The number of Ki67-immunoreactive cells was quantitatively increased in patients with RE as shown in Fig. 3 . In the granular cell layer, proliferative cells had a significant increase (Fig. 3D) in patients with RE when compared with autopsy control patients (p b 0.0001, ANOVA with Bonferroni's multiple comparison test value = 5.543). This did not seem to happen in the hippocampal pyramidal cell layer, in which a low increase was observed but not statistically significant (p N 0.05).
In addition, Sox2-immunopositive cell counting in the DG portion of the hippocampus was performed in patients with RE and compared with control autopsy cases. The DG is a known neurogenic region in the hippocampus that can be accessed by immune tools, and Sox2 immunostaining have been shown as a good pluripotency marker. The counting of immunoreactive cells for the pluripotency-related Sox2 in the granular layer of the DG, in both controls and patients with RE, was used to characterize the pattern of newly born cells in the disease. Semiquantitative measurement was also performed and showed no numerical difference between groups (Fig. 4) .
Expression pattern and characterization of the intermediate neurofilament nestin
With the view to investigate the expression of the intermediate neurofilament nestin, immunostaining was performed for this protein by using an anti-nestin antibody. Many studies have shown that neural progenitor cells uncommitted to a phenotype express this protein.
After phenotypic commitment, the cell begins to express specific markers for neurons or glia. Because of this, the marker has been widely used to characterize neural progenitor cells. Fig. 5 shows the distinct staining pattern between a control autopsy case and a patient with RE. Aiming at characterizing the pattern of newly born cells in the DG of patients with RE, we performed nestin and β-III tubulin double-staining since both are microtubule-associated proteins expressed by developing neurons, as shown in Figs. 6 and 7, respectively.
BDNF expression in patients with RE is increased in comparison with autopsy control cases
The BDNF is a neurotrophin with remarkable function in neuronal survival and differentiation; for this reason, a double immunofluorescence for BDND combined with nestin ( Fig. 8) and NeuN (Fig. 9) was done in both patients with RE and autopsy control cases. The aim was to investigate the occurrence of this neurotrophin in the disease at the hippocampus as well as to address this event. Neurons in the hippocampus express BDNF, as NeuN-positive cells were conspicuously colabeled with BDNF (Fig. 9) . To evaluate if newly born cells in the hippocampus exhibited this protein, we investigated the BDNF colocalization with nestin, which was different in both groups since only few cells marked with both antibodies were found in patients with RE and controls displayed no positive staining for BDNF, as shown in Fig. 8 .
Discussion
Our results showed that there was no difference in neuronal counting when comparing patients with RE to the autopsy group. Histopathological findings regarding astrocyte cells in the hippocampal pyramidal cell layer found no statistically significant change in astrocyte numbers in patients with RE compared with controls; in contrast, astrocytosis analysis in the DG region showed that there was an astrocytic decrease in this region in patients with RE. Furthermore, in the analyzed areas, we observed an increase in the rate of cell division markers in RE, positive marking for Ki67 in the DG, and expressive nestinpositive cell increase even though the number of Sox2-positive cells was not changed. In other words, there was an increase in cell proliferation but not in adult neural stem cells.
These data suggest that there is a decrease in astrocytes in the hippocampus of patients with RE that can be caused by tissue damage or by compromised hippocampal neurogenesis. Studies suggest that newly born astrocytes are more commonly generated in the SVZ compared with the DG [42] . This difference in the expression of adult neurogenesis could be reflecting the histopathological findings observed here. The fact that the cortex is more severely affected with regard to inflammation in RE could also explain the spatial location of astrogenesis expression in the patients analyzed here. However, there was no available SVZ tissue for this study that could have been used to compare these two neurogenic areas in RE.
These results are in agreement with the study by Bauer et al. [43] , in which they attributed the reduction of astrocytes to the direct attack of T lymphocytes, not only against neurons, as widely described in this disease, but also a possible astrocyte-directed attack [43] . This astrocyte reduction was observed in the present study, and the main region that presented expressive astrocytic decrease was the DG, a neurogenic hippocampal niche, which may represent a threat to the trophic support provided by astrocyte cells.
Additionally, in relation to the data on the expression of cell proliferation markers, a possible reasonable explanation about this result could be that, in this disease, neuronal stem cells are forced by the microcellular environment to undergo cell division; however, they may be dying quickly in response to the extremely hostile environment due to tissue inflammation.
Moreover, neural precursor cells were labeled in the DG of patients with RE to evaluate neurogenesis, a process in which neural progenitor cells proliferate in neurogenic niches, which are biological microenvironments produced by cells, extracellular substrates, and signals that mediate neuronal and glial differentiation. Anti-nestin immunolabeling has been widely used to characterize neurogenesis [44] . This protein is widely expressed during developing and adult phases. In the latter, nestin is expressed in the neural precursor cells in the SGZ [45] . When the cell follows its normal developmental program, there is a decrease in its expression and substitution of this intermediate filament for some other specific adult cell line. During neurogenesis and gliogenesis, nestin is gradually replaced by neurofilaments and GFAP, respectively, as cell maturation occurs.
In this study, we also investigated the cellular pluripotency rate in the hippocampus of patients with RE using the anti-Sox2 immunofluorescence technique, a transcription factor coupled to genes related to embryonic development, which is critically related to early embryogenesis and pluripotency of embryonic stem cells. This transcriptional factor is usually found in the subventricular area of the developing brain, and it is also able to maintain neural stem cells undifferentiated by the neutralization of proneural protein activity, thus suspending neural differentiation [46] .
In the present study, the analysis of Sox2 tissue expression, an early neural stem cell/precursor cell type marker, did not show a statistically significant difference between patients with RE and control individuals, which indicates the absence of cells in proliferative activity; however, nestin expression was observed, which may suggest that, when development is completed, such cells leave the pluripotency stage, but the nestin marker still remains in the cells. These data naturally vary among patients because the clinical condition of each patient is unique, but in most cases, they already have long-term epilepsy, which may be causing a decrease in the number of pluripotent cells. Rasmussen's encephalitis remains a challenge to the scientific community as well as raising a huge interest in enabling the understanding of the link between the strong inflammatory factor and epilepsy and this combined influence on neurogenesis, learning, and memory, developmental processes that are involved in childhood. There is a current consensus about the detrimental role of inflammatory insults in the developing brain [47] .
Recent studies have shown that the process of neurogenesis can occur throughout life, but in childhood, it is more robust compared with other stages of life. The hippocampus has a special role in neurogenesis, more specifically the DG subgranular layer [18, [48] [49] [50] [51] . Here, we demonstrated that there is an increase of Ki67-immunoreactive cells on the hippocampal DG subfield of patients with RE. A previous study showed colocalization with Ki67 and nestin antigen in human samples, more specifically in the hilus and subgranular layer, which may indicate that these cell precursors proceed through the cell cycle [44] . Neurogenesis is characterized as a multistep process involving proliferation, differentiation, and migration of multipotent undifferentiated neural stem cells that give rise to NPCs that can differentiate into neurons, astrocytes, or oligodendrocytes [49] . Countless studies have put big effort to understand and explain neurogenesis both during brain development and in the adult brain. Detrimental effects of inflammation in neurogenesis have been proposed and, now, it is known that proinflammatory cytokines exert a negative influence on neurogenesis in the embryonic stage [52, 53] . The role of new neurons is not clear yet; however, some studies have been proposing that they are useful for storing and retrieving memories. Snyder and coworkers showed that Long Term Potentiation (LTP) is abolished by radiation-induced ablation of adult neurogenesis, supporting that idea [54] . Regarding the inflammatory activity, it is known that the hippocampus has a high number of proinflammatory cytokines receptors, especially IL-1β [55] , as it is well-established that inflammatory processes have a detrimental effect in hippocampaldependent memory [56] [57] [58] [59] [60] . This present study showed increased anti-β-III tubulin-immunopositive premature neurons in patients with RE, perhaps an attempt of the brain to numerically preserve granule cells in the DG.
The neurotrophin BDNF has been investigated regarding its colocalization with neurons and newly born cells. This neurotrophin is present in epileptic conditions and is considered an enhancer of tissue damage, which might occur through a BDNF-induced increase in excitability [37] . These data point to a possible link between BDNF and reduction of inhibitory functions of the GABAergic system in mature neurons. It follows that beyond its important role as an inhibitory neurotransmitter, GABA might play a role as an excitatory neurotransmitter contributing to excitotoxicity and neuronal death [61, 62] . We hypothesize here that BDNF might contribute to the described pathological events, which may underlie neuronal damage in RE.
More extensive studies using cell culture and molecular biology should be performed to clarify these findings.
Because of the difficulty in accessing brain tissue and, more importantly, because it is a rare disease, few studies have been published about this correlation. In the present study, our group demonstrated that patients with RE show a significant increase in proliferative activity compared with controls. It is not yet understood which process mostly influences neurogenesis rate: inflammation or seizure. Extramolecular and experimental animal researches are necessary to clarify this process. Future studies should address molecular targets to describe the relation between inflammation and epilepsy on newly born cells in RE.
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